Vistagen Therapeutics (VTGN) Stock Chart & Stock Price History $2.59 -0.04 (-1.52%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$2.72 +0.13 (+5.17%) As of 03/28/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vistagen Therapeutics Stock Price Performance 5 Day Performance-7.17%1 Month Performance-4.07%3 Month Performance-7.83%6 Month Performance-13.95%Year-To-Date Performance-12.20%1 Year Performance-50.95% Receive VTGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address VTGN Stock Chart for Monday, March, 31, 2025 VTGN Chart by TradingViewRemove Ads Vistagen Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025$2.63$2.59-1.52%$2.69$2.56100,871 shs$74.75 million03/27/2025$2.64$2.63-0.38%$2.68$2.5978,931 shs$75.91 million03/26/2025$2.79$2.64-5.38%$2.85$2.58173,218 shs$76.20 million03/25/2025$2.91$2.79-4.12%$2.96$2.76153,119 shs$80.53 million03/24/2025$2.79$2.91+4.30%$2.94$2.78167,659 shs$83.99 million03/21/2025$2.77$2.79+0.72%$2.81$2.7382,346 shs$80.53 million03/20/2025$2.72$2.77+1.84%$2.84$2.62206,572 shs$79.95 million03/19/2025$2.70$2.72+0.74%$2.78$2.61106,669 shs$78.51 million03/18/2025$2.82$2.70-4.26%$2.85$2.69113,482 shs$77.93 million03/17/2025$2.70$2.82+4.44%$2.86$2.67142,326 shs$81.39 million Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025$2.72$2.70-0.74%$2.77$2.63125,306 shs$77.93 million03/13/2025$2.79$2.72-2.51%$2.81$2.6651,879 shs$78.51 million03/12/2025$2.72$2.79+2.57%$2.84$2.7244,860 shs$80.53 million03/11/2025$2.65$2.72+2.64%$2.77$2.5972,445 shs$78.51 million03/10/2025$2.76$2.65-3.99%$2.83$2.62121,644 shs$76.48 million03/07/2025$2.67$2.76+3.37%$2.83$2.62172,793 shs$79.66 million03/06/2025$2.70$2.67-1.11%$2.69$2.56141,072 shs$77.06 million03/05/2025$2.65$2.70+1.89%$2.72$2.61109,367 shs$77.93 million03/04/2025$2.49$2.65+6.43%$2.67$2.35264,202 shs$76.48 million03/03/2025$2.70$2.49-7.78%$2.72$2.48127,809 shs$71.87 million02/28/2025$2.54$2.70+6.30%$2.73$2.51128,563 shs$77.93 million Related Companies AMLX Stock Price Chart ATYR Stock Price Chart CMPX Stock Price Chart AQST Stock Price Chart TECX Stock Price Chart ATAI Stock Price Chart TERN Stock Price Chart PROK Stock Price Chart ANNX Stock Price Chart GOSS Stock Price Chart Receive VTGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VTGN) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vistagen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vistagen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
